% | $
Quotes you view appear here for quick access.

Cytokinetics, Incorporated Message Board

  • afriendofthedevilsafriendofmine afriendofthedevilsafriendofmine Sep 14, 2013 2:14 PM Flag

    Motley video

    He says he likes the chances of our heart failure drug but would buy the safer AMGN over CYTK. With one company's market cap more than 360 times that of the other, I find it hard to imagine that is the correct play on omecamtiv mecarbil, or this technology in general. If one is risk adverse, buy a smaller stake.

    If one is interested in playing AMGN's pipeline (I am not) then buy AMGN. But the video is about heart failure treatment.


    SortNewest  |  Oldest  |  Most Replied Expand all replies
7.02+0.17(+2.48%)Feb 12 4:00 PMEST